mesothelioma study

Disparities and Low Participation in Clinical Trials

by Jadmin Mostel, Patient Support and Research Assistant, Mesothelioma Applied Research Foundation
This past March, I attended the National Comprehensive Cancer Network (NCCN) annual conference, and observed a dynamic roundtable discussion about disparities in the medical field. As the conversation was first colored with various factors such as socioeconomic background and language barriers, the conversation took […]


An Interview with Bonnie Anderson on the Importance of Mesothelioma Research

Diagnosed with mesothelioma in 2002, Bonnie Anderson is a 15-year warrior. Throughout this time, she and her husband, John, have been ardent supporters of the Meso Foundation and have established themselves as leading advocates within the mesothelioma community. Through the Mesothelioma Applied Research Foundation’s peer-review research grant program, they personally funded two research studies:

Exploiting Nf2/Merlin […]


Dr. Anna Nowak Selected as Recipient of the Pioneer Award

Dr. Anna Nowak, medical oncologist, is this year’s recipient of the Pioneer Award for her exceptional achievements and dedication in mesothelioma research.
The Mesothelioma Applied Research Foundation presents the award annually to thought-leaders and allies who have substantially contributed to the advancement of mesothelioma research, treatment, care, support, education, and advocacy.
The award will be presented at […]


Meet Marjorie Zauderer, MD, of Memorial Sloan Kettering Cancer Center

On Tuesday, November 1, the Meso Foundation held a Meet the Mesothelioma Experts session with Marjorie Zauderer, MD, of Memorial Sloan Kettering Cancer Center (MSKCC).
During the call, Dr. Zauderer discussed her work as a medical oncologist at MSKCC in an interview with Mary Hesdorffer, the Meso Foundation’s executive director and expert nurse practitioner.
Dr. Zauderer specializes […]


BREAKING NEWS FROM ASCO: Avelumab Results for Mesothelioma Treatment Released

Dr. Raffit Hassan of the National Cancer Institute, and former chair of the Mesothelioma Applied Research Foundation’s Science Advisory Board, announced results of the Phase 1 clinical trial of avelumab at the most recent ASCO (American Society of Clinical Oncology) meeting in Chicago.
Avelumab, an anti-PD-L1 antibody, works on the basis of boosting the immune system. […]